Colossal Wrongdoings by Big Pharma – Johnson & Johnson – Asrar Qureshi’s Blog Post #1091
Dear Colleagues! This is Asrar Qureshi’s Blog Post #1091 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com for publishing your contributions here.
Preamble
For more than a century, Johnson & Johnson (J&J) has been a household name, synonymous with trust, safety, and family care. Its iconic baby powder, first introduced in 1894, became a staple in homes across the globe. Marketed as gentle and safe for newborns and adults alike, it symbolized purity and reliability. However, behind this wholesome image lies a darker truth—one that has erupted into one of the most significant product liability scandals in recent history.
The Johnson & Johnson talcum powder scandal centers on claims that the company’s talc-based products were contaminated with asbestos—a known carcinogen—and that J&J knew about this risk for decades but failed to disclose it. This blog post is about this scandal, its legal and scientific implications, and the broader lessons for corporate accountability and consumer protection.
J&J’s Talcum Powder – The Product and the Problem
Talc is a naturally occurring mineral composed of magnesium, silicon, and oxygen. In its purest form, talc is safe. However, talc deposits are often found near asbestos, another mineral with fine fibers that can cause serious diseases such as mesothelioma, ovarian cancer, and lung cancer when inhaled.
Johnson & Johnson used talc as the primary ingredient in its baby powder and other personal care products. Concerns about asbestos contamination in talc first emerged in the 1970s. Independent studies and internal memos from that era indicated the potential for asbestos contamination, but J&J insisted its talc products were asbestos-free and safe.
The Allegations
The controversy exploded into public view after a 2018 Reuters investigation revealed that J&J had known for decades about the possibility of asbestos contamination in its talc. Internal company documents, memos, and reports dating back to the 1950s allegedly showed:
- Positive asbestos test results in samples of J&J’s talc products from the 1950s through the early 2000s.
- Concerns among company executives about how to handle these findings and what information to disclose to regulators and consumers.
- Efforts to influence scientific research and challenge regulatory scrutiny.
Despite this evidence, the company continued to market its baby powder as safe and even suitable for daily use.
The Legal Avalanche
Following the Reuters report, thousands of lawsuits were filed against Johnson & Johnson by consumers who claimed they developed ovarian cancer or mesothelioma (type of cancer that develops from the thin layer of tissue, most commonly affected is the lining of the lungs and chest wall) due to long-term use of the company’s talcum powder. Plaintiffs argued that J&J:
- Knew its talc products were contaminated with asbestos.
- Failed to warn consumers about the potential health risks.
- Engaged in misleading marketing that downplayed or denied those risks.
The legal fallout was swift and severe.
- By 2020, over 38,000 lawsuits had been filed.
- In 2018, a St. Louis jury awarded $4.7 billion to 22 women who alleged that J&J’s talcum powder caused their ovarian cancer.
- While some verdicts were overturned on appeal, others were upheld, and J&J began facing mounting financial pressure.
In response, the company decided to stop selling talc-based baby powder in North America in 2020, citing declining demand and misinformation about the product’s safety.
The Texas Two-Step Effort
Facing thousands of lawsuits and potential liability in the billions, Johnson & Johnson employed a controversial legal strategy known as the “Texas Two-Step.” In 2021, the company created a subsidiary, LTL Management LLC, and transferred all talc-related liabilities to it. LTL then promptly filed for bankruptcy.
This maneuver effectively shielded J&J’s main assets from talc litigation while capping its liability exposure. Critics slammed the move as an abuse of the bankruptcy system, accusing J&J of avoiding justice for victims. Plaintiffs and legal experts called it a delay tactic aimed at forcing lower settlements.
A U.S. appeals court initially ruled that the bankruptcy was not filed in good faith and dismissed it. However, J&J continued to pursue legal avenues to reintroduce the strategy. The controversy over the Texas Two-Step illustrates the growing concern over how large corporations use complex legal structures to avoid accountability.
On September 20, 2024, another newly formed subsidiary called Red River Talc filed for bankruptcy in Texas. The judge overseeing the case, however, rejected the bankruptcy. This was their third attempt at shielding behind bankruptcy. J&J has said it plans to focus on the talc litigation going forward instead of appealing the bankruptcy decision.
Scientific Debate and Regulatory Gaps
One of the most contentious aspects of the talc powder scandal is the scientific debate over the presence and risk of asbestos in talc.
- Some studies found no statistically significant link between talc use and ovarian cancer.
- Other studies, along with court testimony from expert witnesses, argued that asbestos contamination and chronic talc use could indeed increase cancer risk.
The U.S. Food and Drug Administration (FDA) has conducted limited testing, often relying on voluntary submission of samples from companies. In 2019, the FDA found asbestos in a sample of J&J’s baby powder, prompting a recall of 33,000 bottles. J&J disputed the findings, insisting the results were erroneous.
This conflicting evidence and fragmented regulatory oversight have made it difficult to arrive at a definitive conclusion. However, the growing body of litigation and consumer concern has irreversibly damaged trust in J&J’s talc products.
Corporate Accountability and Brand Impact
Johnson & Johnson has long cultivated a reputation for integrity, rooted in its famous “Credo”—a guiding document that places the needs of patients and consumers first. The talc powder scandal has severely undermined that image.
- Consumer advocacy groups have called for stronger regulation of personal care products.
- Healthcare providers have become more cautious in recommending talc-based items.
- J&J’s decision to replace talc with cornstarch-based alternatives worldwide (announced in 2022) was seen as an acknowledgment of shifting public trust.
Despite its denials and legal maneuvers, J&J has already spent billions in legal costs and settlements, and the litigation continues. The company’s attempt to draw a line under the scandal has been complicated by ongoing appeals, regulatory scrutiny, and consumer skepticism.
Lessons and Implications
The J&J talc scandal offers critical lessons for companies, regulators, and consumers alike:
- Companies must disclose potential risks transparently. The failure to do so, even if the science is inconclusive, can lead to catastrophic loss of trust.
- Legal strategies like the Texas Two-Step may offer short-term relief but can backfire by attracting public and legal condemnation.
- There is a clear need for more rigorous testing, better labeling standards, and regulatory vigilance in consumer product safety.
- Public perception plays a vital role in brand longevity. J&J’s decision to pivot to cornstarch suggests it ultimately had to respond to consumer concerns.
- Companies may escape immediate consequences through denials or legal complexity, but accountability—financial, reputational, and moral—catches up eventually.
Sum Up
As of April 2025, J&J has 58,208 pending talcum powder lawsuits in multidistrict litigation. They have tried several times to resolve the litigations through a settlement, but did not have success.
Johnson & Johnson’s baby powder was once a symbol of care, comfort, and innocence. Today, it serves as a cautionary tale of how ignoring emerging evidence and prioritizing profit over precaution can lead to corporate downfall and public distrust.
As the lawsuits play out and regulatory reforms loom, the talc scandal will continue to shape the future of consumer safety in the pharmaceutical and personal care industries. For J&J, the long road to restoring public confidence may require more than just courtroom victories—it may demand a recommitment to the values it once claimed to hold dear.
Concluded.
Disclaimers: Pictures in these blogs are taken from free resources at Pexels, Pixabay, Unsplash, and Google. Credit is given where available. If a copyright claim is lodged, we shall remove the picture with appropriate regrets.
For most blogs, I research from several sources which are open to public. Their links are mentioned under references. There is no intent to infringe upon anyone’s copyrights. If, however, it happens unintentionally, I offer my sincere regrets.